KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aehr Test Systems (AEHR) Research & Development (2016 - 2025)

Historic Research & Development for Aehr Test Systems (AEHR) over the last 15 years, with Q4 2025 value amounting to $3.0 million.

  • Aehr Test Systems' Research & Development rose 3058.0% to $3.0 million in Q4 2025 from the same period last year, while for Nov 2025 it was $11.6 million, marking a year-over-year increase of 3046.94%. This contributed to the annual value of $10.5 million for FY2025, which is 2000.23% up from last year.
  • According to the latest figures from Q4 2025, Aehr Test Systems' Research & Development is $3.0 million, which was up 3058.0% from $2.8 million recorded in Q3 2025.
  • In the past 5 years, Aehr Test Systems' Research & Development registered a high of $3.1 million during Q1 2025, and its lowest value of $903000.0 during Q1 2021.
  • Moreover, its 5-year median value for Research & Development was $2.1 million (2023), whereas its average is $2.0 million.
  • Its Research & Development has fluctuated over the past 5 years, first skyrocketed by 6932.45% in 2022, then plummeted by 452.73% in 2024.
  • Quarter analysis of 5 years shows Aehr Test Systems' Research & Development stood at $1.3 million in 2021, then increased by 18.13% to $1.6 million in 2022, then grew by 27.14% to $2.0 million in 2023, then increased by 15.42% to $2.3 million in 2024, then soared by 30.58% to $3.0 million in 2025.
  • Its Research & Development stands at $3.0 million for Q4 2025, versus $2.8 million for Q3 2025 and $2.7 million for Q2 2025.